0001104659-20-114903.txt : 20201014 0001104659-20-114903.hdr.sgml : 20201014 20201014161643 ACCESSION NUMBER: 0001104659-20-114903 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20201013 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201014 DATE AS OF CHANGE: 20201014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Liquidia Technologies Inc CENTRAL INDEX KEY: 0001330436 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38601 FILM NUMBER: 201239231 BUSINESS ADDRESS: STREET 1: 419 DAVIS DRIVE STREET 2: SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-328-4400 MAIL ADDRESS: STREET 1: P.O. BOX 110085 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 8-K 1 tm2033224-1_8k.htm FORM 8-K
0001330436 false 0001330436 2020-10-13 2020-10-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 13, 2020

 

LIQUIDIA TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

 

Delaware   001-38601   20-1926605
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

     
419 Davis Drive, Suite 100, Morrisville, North Carolina   27560
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (919) 328-4400

 

 
(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock LQDA Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

 

 

 

 

 

 

Item 8.01

Other Events.

 

On October 14, 2020, Liquidia Technologies, Inc., a Delaware corporation, announced that the U.S. Patent Trial and Appeal Board (PTAB) has instituted an inter partes review against U.S. Patent No. 9,604,901 and concurrently denied institution on U.S. Patent No. 9,593,066, both owned by United Therapeutics Corporation and listed in the Orange Book for Tyvaso® (treprostinil).

 

A copy of the press release announcing the decisions of the PTAB is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)

 

Exhibit
No.
  Exhibit
99.1   Press Release of Liquidia Technologies, Inc., dated October 14, 2020.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

October 14, 2020 Liquidia Technologies, Inc.
   
   
  By: /s/ Steven Bariahtaris
    Name: Steven Bariahtaris
    Title: Interim Chief Financial Officer

 

 

 

EX-99.1 2 tm2033224d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

Liquidia Technologies, Inc.

419 Davis Drive, Suite 100

Morrisville, NC 27560

 

MEDIA RELEASE

 

www.liquidia.com

 

Liquidia Provides Update on U.S. Patent Trial and Appeal Board Decision on Inter Partes Review of Two United Therapeutics’ Tyvaso® Patents

 

PTAB Institutes Inter Partes Review Proceeding Against United Therapeutics’

‘901 Patent and Denies Institution on ‘066 Patent for Tyvaso®

 

RESEARCH TRIANGLE PARK, N.C., October 14, 2020 - Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology, today announced that the U.S. Patent Trial and Appeal Board (PTAB) has instituted inter partes review (IPR) against U.S. Patent No. 9,604,901 (‘901) and concurrently denied institution on 9,593,066 (‘066), both owned by United Therapeutics Corporation (UTC) and listed in the Orange Book for Tyvaso® (treprostinil).

 

For ‘901, the PTAB Institution Decision states that “based on the information presented, we institute an inter partes review of claims 1–9 of the ’901 patent.”

 

Conversely, for ‘066, the PTAB denied institution of IPR stating that the petition “has not established a reasonable likelihood that it would prevail in showing that at least one of the challenged claims is unpatentable.”

 

“The PTAB’s decision to institute an IPR proceeding against the ‘901 patent for Tyvaso is another important step forward for Liquidia’s ongoing effort to bring LIQ861, a convenient and well tolerated treatment option, to the PAH community,” stated Neal Fowler, Chief Executive Officer at Liquidia. “We believe PTAB’s decision on ‘066 to be in error and while there are options for reconsideration, we remain confident in the arguments of non-infringement and invalidity to be made in district court.”

 

Mr. Fowler added, “The Liquidia management team and our board are committed to providing PAH patients with alternative treatment options, like LIQ861, that we believe they need and deserve. We will not be deterred by any effort to limit our ability to deliver on this goal for patients and are confident in our options to bring LIQ861 to commercialization.”

 

Liquidia’s 505(b)(2) New Drug Application (NDA) for LIQ861, a dry powder inhalation of treprostinil, is currently under active review by the U.S. Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension (PAH). Tyvaso®, a nebulized treprostinil solution, is the Reference Listed Drug for the LIQ861 NDA.

 

On June 4th, UTC filed a lawsuit against Liquidia under the Hatch-Waxman Act, based on the LIQ861 NDA, for infringement of Tyvaso patents that triggered a 30-month stay on an FDA regulatory approval. The 30-month stay expires on the earlier of October 24, 2022 or resolution of the litigation, whichever occurs first.

 

 

 

 

 

 

Liquidia Technologies, Inc.

419 Davis Drive, Suite 100

Morrisville, NC 27560

 

MEDIA RELEASE

 

www.liquidia.com

 

In July, UTC filed an amended complaint asserting infringement of an additional recently issued U.S. Patent No. 10,716,793 (‘793). Although UTC’s amended complaint brings the ‘793 patent into the pending lawsuit, the statutory 30-month stay on regulatory approval, is not associated with the allegations of infringement of the ‘793 patent and the allegations of infringement of this patent should have no effect on the FDA’s review of the LIQ861 NDA.

 

About Liquidia

Liquidia is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. Currently, Liquidia is focused on the development of two product candidates for which it holds worldwide commercial rights: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. Liquidia is headquartered in Research Triangle Park, NC. For more information, please visit www.liquidia.com.

 

Cautionary Statements Regarding Forward-Looking Statements

 

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release other than statements of historical facts, including statements regarding our future results of operations and financial position, our strategic and financial initiatives, our business strategy and plans and our objectives for future operations, are forward-looking statements. Such forward-looking statements, including statements regarding clinical trials, clinical studies and other clinical work (including the funding therefor, anticipated patient enrollment, safety data, study data, trial outcomes, timing or associated costs), regulatory applications and related timelines, including potential U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA) for LIQ861, the timeline or outcome related to our patent litigation pending in the U.S. District Court for the District of Delaware or two petitions for inter partes review with the Patent Trial and Appeal Board, the issuance of patents by the USPTO and our ability to execute on our strategic or financial initiatives, involve significant risks and uncertainties and actual results could differ materially from those expressed or implied herein. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “would,” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs. These forward-looking statements are subject to a number of risks discussed in our and Liquidia Corporation’s filings with the Securities and Exchange Commission, including the risk that our proposed acquisition of RareGen, LLC is not consummated or that the expected benefits and synergies from the proposed acquisition are not realized, the impact of the coronavirus (COVID-19) outbreak on our company and our financial condition and results of operations, as well as a number of uncertainties and assumptions. Moreover, we operate in a very competitive and rapidly changing environment and our industry has inherent risks. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Nothing in this press release should be regarded as a representation by any person that these goals will be achieved, and we undertake no duty to update our goals or to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Contact Information

Media
:
Michael Parks
Corporate Communications
484.356.7105
michael.parks@liquidia.com

 

Investors:
Jason Adair
Vice President, Corporate Development and Strategy
919.328.4400
jason.adair@liquidia.com

 

 

 

GRAPHIC 3 tm2033224d1_ex99-1img01.jpg GRAPHIC begin 644 tm2033224d1_ex99-1img01.jpg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end EX-101.SCH 4 lqda-20201013.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 lqda-20201013_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 lqda-20201013_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 tm2033224-1_8k_htm.xml IDEA: XBRL DOCUMENT 0001330436 2020-10-13 2020-10-13 iso4217:USD shares iso4217:USD shares 0001330436 false 8-K 2020-10-13 LIQUIDIA TECHNOLOGIES, INC. DE 001-38601 20-1926605 419 Davis Drive Suite 100 Morrisville NC 27560 919 328-4400 false false false false Common stock LQDA NASDAQ true true XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Cover
Oct. 13, 2020
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 13, 2020
Entity File Number 001-38601
Entity Registrant Name LIQUIDIA TECHNOLOGIES, INC.
Entity Central Index Key 0001330436
Entity Tax Identification Number 20-1926605
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 419 Davis Drive
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Morrisville
Entity Address, State or Province NC
Entity Address, Postal Zip Code 27560
City Area Code 919
Local Phone Number 328-4400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock
Trading Symbol LQDA
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period true
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 95 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://liquidia.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2033224-1_8k.htm lqda-20201013.xsd lqda-20201013_lab.xml lqda-20201013_pre.xml tm2033224d1_ex99-1.htm http://xbrl.sec.gov/dei/2020-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2033224-1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "tm2033224-1_8k.htm" ] }, "labelLink": { "local": [ "lqda-20201013_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "lqda-20201013_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "lqda-20201013.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "lqda", "nsuri": "http://liquidia.com/20201013", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2033224-1_8k.htm", "contextRef": "From2020-10-13to2020-10-13", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://liquidia.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2033224-1_8k.htm", "contextRef": "From2020-10-13to2020-10-13", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-US": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 15 0001104659-20-114903-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-20-114903-xbrl.zip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end